✨
Yapay Zeka Hızlı Bakış & Çıkarımlar
AI Insight⚡ TL;DR(1 Cümlede Hızlı Çıkarım)
In this report, the effect of approximately 1 year of progesterone treatment in a patient with LAM, presenting with recurrent pneumothorax, was evaluated.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Lymphangioleiomyomatosis (LAM) is a rare interstitial lung disease.
📊
Temel Bulgular & Veri:Patients with LAM generally present with dyspnea and spontaneous pneumothorax.
💡
Sonuç & Katkı:In this report, the effect of approximately 1 year of progesterone treatment in a patient with LAM, presenting with recurrent pneumothorax, was evaluated.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
Lymphangioleiomyomatosis (LAM) is a rare interstitial lung disease. Patients with LAM generally present with dyspnea and spontaneous pneumothorax. Today, while there is no proven medical treatment method for LAM, progesterone is among the widely used drugs. In this report, the effect of approximately 1 year of progesterone treatment in a patient with LAM, presenting with recurrent pneumothorax, was evaluated.
🔖
Bu Makaleye Atıf Yap
TÜLEK, B., KANAT, F., SÜERDEM, M. (2014). Progesterone Treatment Experience in a Patient with Lymphangioleiomyomatosis Presenting with Recurrent Pneumothorax. Solunum, Cilt: 16 - Sayı: 3, 199–202. https://ajindex.com/articles/314322